Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 7-formyl-6-(4-methyl-2-oxo-piperazin-1-ylmethyl)-3,4-dihydro-2h-(1,8)naphthyridine-1-carboxylic Acid (5-cyano-4-(2-methoxy-ethylamino)-pyridin-2-yl)-amide
2. Fgf401
3. N-(5-cyano-4-(2-methoxyethylamino)pyridin-2-yl)-7-formyl-6-((4-methyl-2-oxopiperazin-1-yl)methyl)-3,4-dihydro-2h-1,8-naphthyridine-1-carboxamide
1. Fgf401
2. 1708971-55-4
3. Fgf-401
4. Roblitinib [inn]
5. N-[5-cyano-4-(2-methoxyethylamino)pyridin-2-yl]-7-formyl-6-[(4-methyl-2-oxopiperazin-1-yl)methyl]-3,4-dihydro-2h-1,8-naphthyridine-1-carboxamide
6. M64jf6wmsa
7. Nvp-fgf401
8. N-(5-cyano-4-((2-methoxyethyl)amino)pyridin-2-yl)-7-formyl-6-((4-methyl-2-oxopiperazin-1-yl)methyl)-3,4-dihydro-1,8-naphthyridine-1(2h)-carboxamide
9. Roblitinib; Fgf-401
10. Unii-m64jf6wmsa
11. Roblitinib [who-dd]
12. Nvp-fgf-401
13. Gtpl9768
14. Chembl3908979
15. Fgf 401 [who-dd]
16. Schembl16668840
17. Fgf 401
18. Bdbm209325
19. Amy39077
20. Bcp25143
21. Ex-a1341
22. Example 83 [us9266883]
23. Nsc804962
24. S8548
25. Fgf-401; Fgf 401; Roblitinib
26. Akos032946374
27. Zinc644165879
28. Ccg-269749
29. Cs-6853
30. Nsc-804962
31. Ac-29896
32. Bs-16207
33. Hy-101568
34. Us9266883, 83
35. A903440
36. Q29213614
37. N-(5-cyano-4-(2-methoxyethylamino)pyridin-2-yl)-7-formyl-6-((4-methyl-2-oxopiperazin-1-yl)methyl)-3,4-dihydro-1,8-naphthyridine-1(2h)-carboxamide
38. N-[5-cyano-4-[(2-methoxyethyl)amino]-2-pyridinyl]-7-formyl-3,4-dihydro-6-[(4-methyl-2-oxo-1-piperazinyl)methyl]-1,8-naphthyridine-1(2h)-carboxamide
39. Roblitinib;n-(5-cyano-4-((2-methoxyethyl)amino)pyridin-2-yl)-7-formyl-6-((4-methyl-2-oxopiperazin-1-yl)methyl)-3,4-dihydro-1,8-naphthyridine-1(2h)-carboxamide
| Molecular Weight | 506.6 g/mol |
|---|---|
| Molecular Formula | C25H30N8O4 |
| XLogP3 | 0.6 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 9 |
| Rotatable Bond Count | 8 |
| Exact Mass | 506.23900147 g/mol |
| Monoisotopic Mass | 506.23900147 g/mol |
| Topological Polar Surface Area | 144 Ų |
| Heavy Atom Count | 37 |
| Formal Charge | 0 |
| Complexity | 865 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
50
PharmaCompass offers a list of Roblitinib API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Roblitinib manufacturer or Roblitinib supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Roblitinib manufacturer or Roblitinib supplier.
PharmaCompass also assists you with knowing the Roblitinib API Price utilized in the formulation of products. Roblitinib API Price is not always fixed or binding as the Roblitinib Price is obtained through a variety of data sources. The Roblitinib Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Roblitinib manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Roblitinib, including repackagers and relabelers. The FDA regulates Roblitinib manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Roblitinib API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Roblitinib supplier is an individual or a company that provides Roblitinib active pharmaceutical ingredient (API) or Roblitinib finished formulations upon request. The Roblitinib suppliers may include Roblitinib API manufacturers, exporters, distributors and traders.
Roblitinib Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Roblitinib GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Roblitinib GMP manufacturer or Roblitinib GMP API supplier for your needs.
A Roblitinib CoA (Certificate of Analysis) is a formal document that attests to Roblitinib's compliance with Roblitinib specifications and serves as a tool for batch-level quality control.
Roblitinib CoA mostly includes findings from lab analyses of a specific batch. For each Roblitinib CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Roblitinib may be tested according to a variety of international standards, such as European Pharmacopoeia (Roblitinib EP), Roblitinib JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Roblitinib USP).
